Atlas Trials

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

Clinical trial NCT03285997 · UNKNOWN

Trial details

NCT number
NCT03285997
Sponsor
Green Cross Corporation
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza Vaccine
Start date
2017-09-30
Primary completion
2018-05-31
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.